J. Albuquerque

SARS-CoV-2 antibody seroprevalence in cancer patients on systemic antineoplastic treatment in the first wave of the COVID-19 pandemic in Portugal

L. Brum, C. Pulido, T. Rodrigues, 2022, medRxiv.

Polyclonal F(ab’)2 fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potency

Carolina Q. Sacramento, A. Tanuri, Jerson L. Silva, 2021, iScience.

Potent neutralizing equine antibodies raised against recombinant SARS-CoV-2 spike protein for COVID-19 passive immunization therapy

Carolina Q. Sacramento, A. Tanuri, Jerson L. Silva, 2020, bioRxiv.

Equine hyperimmune globulin raised against the SARS-CoV-2 spike glycoprotein has extremely high neutralizing titers

Carolina Q. Sacramento, A. Tanuri, Jerson L. Silva, 2020 .